Latest papers

[Follow-up study of programmed intervention of hyperuricemia in the prevention and treatment of cardiovascular morbid change].

[Hyperuricemia: a risk factor of cardiovascular diseases deserving a high priority of exploration and investigation].

Genetics of gout.

Progress in the pharmacotherapy of gout.

A prescription for lifestyle change in patients with hyperuricemia and gout.

Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Uric acid and antioxidant effects of wine.

Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma.

Gout and hyperuricemia.

Update on gout: new therapeutic strategies and options.

Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report.

Cochlear dysfunction in hyperuricemia: otoacoustic emission analysis.

Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.

[Results of experimental study of psychophysiological state and hematological characteristics in servicemen presenting with hyperuricemia].

[Endothelial function in patients with arterial hypertension and impaired uric acid metabolism].

Management of hyperuricemia in gout: focus on febuxostat.

Myelination disturbance in a patient with hyperuricemia and hyperserotoninemia combined with 18q deletion syndrome.

Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly men.

Hyperuricemia associated with rapid renal function decline in elderly Taiwanese subjects.

Montmorillonite adsorbs uric acid and increases the excretion of uric acid from the intestinal tract in mice.